What Is the Point of the Equity Market?
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Venture Capital Firms • Institutional Investors • Corporate Investors • Corporations
BBK34133 | Investment Analysis Prepared by Khairul Anuar L2 - Initial Public Offering & Rights Issue 1 Content Content 1. Sources of Funds for Private Companies 2. Initial Public Offering 3. Advantages and Disadvantages of Going Public 4. Appointment of Advisers 5. The IPO Process 6. Pricing of the IPO Shares 7. IPO Puzzles 8. Raising Additional Capital: The Seasoned Equity Offering 9. Rights Issue 10. Dilution of Percentage Ownership 2 Security Markets Are designed to allow corporations and governments to raise new funds and to allow investors to execute their buying and selling orders. Primary and Secondary Security Markets Primary Market Secondary Market Where corporate and Where previously government entities can issued securities are raise capital traded among investors. In short: All securities are first traded in the primary market, and the secondary market provides liquidity for these securities. 1. Sources of Funding for Private Companies -1 A private company can seek funding from several potential sources: • Angel Investors • Venture Capital Firms • Institutional Investors • Corporate Investors • Corporations 5 1. Sources of Funds for Private Companies -2 Angel Investors • Individual investors who buy equity in small private firms. • For many start-ups, the first round of outside private equity financing is often obtained from „angels‟. Institutional Investors • Include superannuation funds, insurance companies, investment companies and charities. • May invest directly in private firms, or may invest indirectly by becoming investors in venture capital firms. 6 1. Sources of Funding for Private Companies -3 Venture Capital Firms • A venture capital firm specialises in raising money to invest in the private equity of young firms. • Typically, institutional investors, such as superannuation funds, are investors in a venture capital firm. -
Orege Launches a €49.2 Million Rights Issue to Strengthen Its Financial Structure and Fund Its Development
This press release is not intended to be published, released or distributed, directly or indirectly, in the United States of America, Canada, Australia or Japan. Orege launches a €49.2 million rights issue to strengthen its financial structure and fund its development ▪ Rights issue for a maximum amount of approximately €49.2 million ▪ Subscription price: €1.24 per new share, i.e. a nominal discount of 14.48% over the last closing price ▪ Subscription ratio: 85 new shares for 40 existing shares ▪ Detachment of preemptive rights on 28 June 2019 and subscription open from 2 July 2019 to 11 July 2019 inclusive ▪ Commitments and guarantee by the majority shareholder, Eren Industries S.A. and commitments by third- party investors to subscribe for 76.46% of the issue Voisins-le-Bretonneux, 26 June 2019, 7:30am – Orege, an innovative company specialized in municipal and industrial sludge conditioning, treatment and recovery solutions, is announcing the launch of a capital increase through issuing new shares (the “New Shares”) with preemptive rights for a maximum gross total of €49.2 million (“the Rights Issue”). With this operation, Orege aims to strengthen its financial position in order to accelerate the commercial and industrial rampup that began in 2018. The Autorité des marchés financiers (AMF, the French financial markets authority) granted visa number 19- 296 on 25 June 2019 for the Prospectus relating to the Rights Issue, comprising the Document de Référence registered on 25 June 2019 under number R. 19 – 023 and the Note d’Opération (including the summary of the Prospectus). The Rights Issue will reconstitute the Company’s net equity by capitalising a substantial proportion of the shareholder current account held by its majority shareholder, Eren Industries S.A. -
RRP Sector Assessment
OrbiMed Asia Partners III, LP Fund (RRP REG 51072) OWNERSHIP, MANAGEMENT, AND GOVERNANCE A. The Fund Structure 1. The Asian Development Bank (ADB) proposes to invest in OrbiMed Asia Partners III, LP Fund (OAP III), which is a Cayman Islands exempted limited partnership seeking to raise up to $500 million in capital commitments. It is managed by OrbiMed Asia GP III, LP (the general partner), a Cayman Islands exempted limited partnership. The sole limited partner of the general partner is OrbiMed Advisors III Limited, a Cayman Islands exempted company. OrbiMed Advisors LLC (the investment advisor), a registered investment advisor with the United States (US) Securities and Exchange Commission, will provide investment advisory services to OAP III. This structure is illustrated in the figure below. Table 1 shows the ultimate beneficial owners (UBOs) of the general partner and the investment advisor. Table 1: Ultimate Beneficial Owners of the General Partner and the Investment Advisor (ownership stake, %) Name Investment Advisor General Partner Sven H. Borho (~10–25%) (~8%) Alexander M. Cooper (~8%) Carl L. Gordon (~10–25%) (~8%) (also Director) Geoffrey C. Hsu (<5%) (~8%) Samuel D. Isaly (~50–75%) (~8%) W. Carter Neild (<5%) (~8%) (also Director) Jonathan T. Silverstein (~5–10%) (~8%) (also Director) Sunny Sharma (~8%) (also Officer) Evan D. Sotiriou (~8%) David G. Wang (~8%) (also Officer) Jonathan Wang (~8%) (also Officer) Sam Block III (~8%) Source: OrbiMed Group. 2 2. Investors. The fund held a first closing of approximately $233.5 million on 1 March 2017, and a second closing of approximately $137.6 million on 26 April 2017. -
Understanding Private Equity. What Is Private Equity? EXAMPLES of PRIVATELY HELD COMPANIES
Understanding private equity. What is private equity? EXAMPLES OF PRIVATELY HELD COMPANIES: A private equity investor is an individual or entity that invests capital into a private company (i.e. firms not traded on a public exchange) in exchange for equity interest in that business. In the US, there are approximately 18,000 publicly traded companies, and more than 300,000 privately held companies. WHO MIGHT SEEK A PRIVATE EQUITY INVESTOR AS A SOURCE OF CAPITAL? • Companies looking to fund a capital need that is beyond traditional bank financing • Owners considering a partial or complete sale of their business • Managers looking to buy a business Private equity strategies. EXAMPLES OF PRIVATE EQUITY FIRMS: MOST PRIVATE EQUITY INVESTORS WILL LIMIT THEIR INVESTMENTS TO ONE OR TWO OF THE FOLLOWING STRATEGIES: • Angel investing • Growth capital • Venture capital • Distressed investments • Leveraged buyouts (LBO) • Mezzanine capital Sources of capital for PE funds. THERE ARE TWO TYPES OF PRIVATE EQUITY FIRMS: • Firms with a dedicated fund, with the majority of the capital sourced from institutional investors (i.e. pension funds, banks, endowments, etc.) and accredited investors (i.e. high net worth individual investors) • Firms that raise capital from investors on a per-deal basis (pledge funds) INVESTMENT DURATION AND RETURNS. • Typical investment period is 3−10 years, after which capital is distributed to investors • Rates of return are higher than public market returns, typically 15−30%, depending on the strategy HISTORICAL S&P 500 RETURNS S&P 500 Returns Average Source: Standard & Poor’s LCD Private equity fund structure. PRIVATE EQUITY FIRM LIMITED PARTNERS (Investors) (Public pension funds, corporate pension funds, insurance companies, high net worth individuals, family offices, endowments, banks, foundations, funds-of-funds, etc.) Management Company General Partner Fund Ownership Fund Investment Management PRIVATE EQUITY FUND (Limited Partnership) Fund’s Ownership of Portfolio Investments Etc. -
Investor Lunch, New York – 3 March 2006
Investor lunch, New York – 3 March 2006 1 3i team Philip Yea Simon Ball Jonathan Russell Michael Queen Jo Taylor Chris Rowlands Group Chief Executive Group Finance Director Managing Partner Managing Partner Managing Partner Head of Group Markets Buyouts Growth Capital Venture Capital Patrick Dunne Anil Ahuja Gustav Bard Graeme Sword Guy Zarzavatdjian Group Communications Managing Director, India Managing Director, Director, Oil and Gas Managing Director, Director Nordic Region France 2 Investor lunch, New York – 3 March 2006 Contents • Introduction to 3i • The private equity market • Interim results to 30 September 2005 • Investor relations • Closing remarks 3 Investor lunch, New York – 3 March 2006 Introduction to 3i 3i at a glance • A world leader in private equity and venture capital • Established 1945; IPO on London Stock Exchange 1994 (IPO at 272p) • Market capitalisation £5.0bn (as at 31 January 2006) • 3i has invested over £15bn in over 14,000 businesses • Portfolio value £4.4bn, in 1,285 businesses (as at 30 September 2005) • Network of teams located in 14 countries in Europe, Asia and the US • 3i also manages and advises third party funds totalling £1.8bn (as at 30 September 2005) • Member of the MSCI Europe, FTSE100, Eurotop 300 and DJ Stoxx indices 4 Investor lunch, New York – 3 March 2006 Introduction to 3i Our Board • Chairman Baroness Hogg • Six independent non-executive directors − Oliver Stocken (Deputy Chairman; Senior Independent Director) − Dr Peter Mihatsch − Christine Morin-Postel − Danny Rosenkranz − Sir Robert Smith -
Corporate Venturing Report 2019
Corporate Venturing 2019 Report SUMMIT@RSM All Rights Reserved. Copyright © 2019. Created by Joshua Eckblad, Academic Researcher at TiSEM in The Netherlands. 2 TABLE OF CONTENTS LEAD AUTHORS 03 Forewords Joshua G. Eckblad 06 All Investors In External Startups [email protected] 21 Corporate VC Investors https://www.corporateventuringresearch.org/ 38 Accelerator Investors CentER PhD Candidate, Department of Management 43 2018 Global Startup Fundraising Survey (Our Results) Tilburg School of Economics and Management (TiSEM) Tilburg University, The Netherlands 56 2019 Global Startup Fundraising Survey (Please Distribute) Dr. Tobias Gutmann [email protected] https://www.corporateventuringresearch.org/ LEGAL DISCLAIMER Post-Doctoral Researcher Dr. Ing. h.c. F. Porsche AG Chair of Strategic Management and Digital Entrepreneurship The information contained herein is for the prospects of specific companies. While HHL Leipzig Graduate School of Management, Germany general guidance on matters of interest, and every attempt has been made to ensure that intended for the personal use of the reader the information contained in this report has only. The analyses and conclusions are been obtained and arranged with due care, Christian Lindener based on publicly available information, Wayra is not responsible for any Pitchbook, CBInsights and information inaccuracies, errors or omissions contained [email protected] provided in the course of recent surveys in or relating to, this information. No Managing Director with a sample of startups and corporate information herein may be replicated Wayra Germany firms. without prior consent by Wayra. Wayra Germany GmbH (“Wayra”) accepts no Wayra Germany GmbH liability for any actions taken as response Kaufingerstraße 15 hereto. -
Refinitiv Corporate Actions Methodology
REFINITIV EQUITY INDICES Corporate Action Methodology April 2020 Published: April 6, 2020 © 2019 Refinitiv Limited. All Rights Reserved. Refinitiv Limited, by publishing this document, does not guarantee that any information contained herein is or will remain accurate or that use of the information will ensure correct and faultless operation of the relevant service or associated equipment. Neither Refinitiv Limited, nor its agents or employees, shall be held liable to any user or end user for any loss or damage (whether direct or indirect) whatsoever resulting from reliance on the information contained herein. This document may not be reproduced, disclosed, or used in whole or part without the prior written consent of Refinitiv. 1 Sensitivity: Confidential Contents Introduction ......................................................................................................................................... 3 Corporate Actions ............................................................................................................................... 4 1.1 Cash Dividend .......................................................................................................................... 4 1.2 Special Dividend ...................................................................................................................... 5 1.3 Cash Dividend with Stock Alternative ....................................................................................... 5 1.4 Stock Dividend ........................................................................................................................ -
Caris Life Sciences Raises $830 Million in Growth Equity Capital to Continue to Expand Its Precision Medicine Platform
FOR IMMEDIATE RELEASE Caris Life Sciences Raises $830 Million in Growth Equity Capital to Continue to Expand its Precision Medicine Platform Accelerates Caris’ rapid growth as the market leader reshaping precision oncology through basic science research and the application of artificial intelligence to one of the largest clinico-genomic databases Capital raise represents one of the largest private financings in precision medicine supported by a diverse, high-quality syndicate of leading investors IRVING, Texas, May 11, 2021 – Caris Life Sciences®, a leading innovator in molecular science and artificial intelligence (AI) focused on fulfilling the promise of precision medicine, announced an $830 million growth equity round at a post-money valuation of $7.83 billion. With this investment, Caris has raised approximately $1.3 billion in external financing since 2018. This financing represents one of the largest capital raises in precision medicine and includes a diverse syndicate of leading investors. The round was led by Sixth Street, a leading global investment firm making its third investment in Caris since 2018. Funds and accounts advised by T. Rowe Price Associates, Inc., Silver Lake, Fidelity Management & Research Company LLC, and Coatue were significant participants in the round. Additional investors included Columbia Threadneedle Investments, Canada Pension Plan Investment Board, Millennium Management, Neuberger Berman Funds, Highland Capital Management, Rock Springs Capital, OrbiMed, ClearBridge Investments, Tudor Investment Corporation, Eaton Vance Equity (Morgan Stanley), Pura Vida Investments and First Light Asset Management. All existing investors from the 2020 financing participated in this deal along with a number of new investors. The Caris Molecular Intelligence approach allows oncologists to assess all 22,000 genes in both DNA and RNA, utilizing whole exome sequencing, whole transcriptome sequencing, protein analysis, and proprietary AI models and signatures. -
Market Reaction to Rights Offering Announcements in the Turkish Stock Market
MARKET REACTION TO RIGHTS OFFERING ANNOUNCEMENTS IN THE TURKISH STOCK MARKET A THESIS SUBMITTED TO THE GRADUATE SCHOOL OF APPLIED MATHEMATICS OF MIDDLE EAST TECHNICAL UNIVERSITY BY METE TEPE IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF MASTER OF SCIENCE IN FINANCIAL MATHEMATICS JANUARY 2012 Approval of the thesis: MARKET REACTION TO RIGHTS OFFERING ANNOUNCEMENTS IN THE TURKISH STOCK MARKET submitted by METE TEPE in partial fulfillment of the requirements for the degree of Master of Science in Department of Financial Mathematics , Middle East Technical University by, Prof. Dr. Ersan Akyıldız ____________ Director, Graduate School of Applied Mathematics Assoc. Prof. Dr. Ömür U ğur ____________ Head of Department, Financial Mathematics Assist. Prof. Dr. Seza Danı şoğlu ____________ Supervisor, Department of Business Administration, METU Examining Committee Members: Prof. Dr. Gerhard-Wilhelm Weber ____________ Department of Financial Mathematics, METU Assist. Prof. Dr. Seza Danı şoğlu ____________ Department of Business Administration, METU Prof. Dr. Zehra Nuray Güner ____________ Department of Business Administration, METU Assoc. Prof. Dr. Azize Hayfavi ____________ Department of Financial Mathematics, METU Assoc. Prof. Dr. Zeynep Önder ____________ Department of Management, Bilkent University Date: ____________ I hereby declare that all information in this document has been obtained and presented in accordance with academic rules and ethical conduct. I also declare that, as required by these rules and conduct, I have fully cited and referenced all material and results that are not original to this work. Name, Last Name : METE TEPE Signature : iii ABSTRACT MARKET REACTION TO RIGHTS OFFERING ANNOUNCEMENTS IN THE TURKISH STOCK MARKET Tepe, Mete M.Sc., Department of Financial Mathematics Supervisor : Assist. -
Eurazeo Confirms Its Excellent Growth
EURAZEO CONFIRMS ITS EXCELLENT GROWTH MOMENTUM IN THE FIRST QUARTER OF 2021: AUM +21% OVER 12 MONTHS AND REVENUES +20% EXCLUDING TRAVEL AND LEISURE Paris, May 20, 2021 Asset management momentum strengthens at end-March • Assets Under Management (AUM): €22.7bn, +21% over LTM, of which +27% for third party • Third-party fundraising: €785m at end-March and c.€1,200m YTD, versus €283m in Q1 2020 • Management fees: €59m, of which +13% for limited partners (+4% overall1 given balance sheet divestments) • The Group expects further growth in fundraising in 2021 thanks to the strong market attractiveness of its current funds, particularly for small-mid buyout, growth and private debt funds Strong growth in portfolio performance • Portfolio economic revenue2 up +20% in Q1 2021 year-on-year (+15% compared to Q1 2019), excluding the Travel & Leisure segment • 61% increase in revenues of Growth portfolio companies (non-consolidated) • Early recovery prospects in Travel & Leisure (10% of NAV) Sustained investment activity • €1.1bn invested (€0.5bn in Q1 2020), with business flows in buoyant sectors notably tech (Questel, PPRO, Message Bird), consumer tech (UPD, Aroma-Zone) and financial services (Groupe Premium) • A high level of asset divestments expected in 2021-2022, as announced Balance sheet remains robust • NAV per share of €85.5 (not revalued quarterly) • Net cash and cash equivalents of €255m at end-March – confirmed RCF of €1.5bn • Dry powder of €3.7bn Virginie Morgon, Chairwoman of the Executive Board, stated: “This first quarter of 2021 reflects Eurazeo's growth momentum in all aspects of its business. The growth in our fundraising and assets under management, but also the strong rebound in our portfolio activity, the sustained pace of our investments in growth sectors, value-creating exits and our ability to support the major shifts towards a more sustainable economy perfectly illustrate our "Power Better Growth" positioning and its attractiveness. -
Unpacking Private Equity Characteristics and Implications by Asset Class
Unpacking Private Equity Characteristics and Implications by Asset Class www.mccombiegroup.com | +1 (786) 664-8340 Unpacking Private Equity: Characteristics & implications by asset class The term private equity is often treated as a catchall, used interchangeably to describe a broad variety of investments. Such loose use of the phrase fails to capture the range of nuanced business ownership strategies it refers to and risks branding an entire asset class with characteristics and implications that are typically relevant to only a particular sub-category. Recently, this has especially been the case given the outsized global attention placed on the leveraged buyout deals of Bain Capital, a private equity firm founded by Republican U.S. presidential candidate Mitt Romney. In this context, popular discourse has inappropriately attached the label of private equity to a general practice of debt-fueled corporate takeovers that disproportionately focus on cost cutting. In reality, however, private equity refers to an array of investment strategies each with a unique risk-return profile and differing core skillsets for success. This article is intended to help family office executives better understand the nuances of the various sub-categories of private equity. It seeks to draw high-level distinctions, serving as a practical guide for investors entering the private equity arena, be it directly or through a more curated fund structure. Ultimately by understanding the characteristics and implications of each asset class, the reader should be equipped to make an educated choice regarding the most relevant and appropriate strategy for their unique profile. From a technical perspective, private equity is nothing more than making investments into illiquid non-publicly traded companies— i.e. -
20Th Annual Growth Capital Symposium June 19-20, 2001 Ann Arbor, Michigan
20th Annual Growth Capital Symposium June 19-20, 2001 Ann Arbor, Michigan University of Michigan Business School presented by: Center for Venture Capital and Private Equity Finance (CVP) The University of Michigan Business School Dr. David J. Brophy, Director www.umich.edu/~cvpumbs sponsored by: THE 20th ANNUAL GROWTH CAPITAL SYMPOSIUM June 19-20, 2001 In the last five years the venture capital industry has experienced a true "boom-and-bust", with unprecedented growth in capital raised and invested, growth in valuations and deal- flow, mostly centered around the internet. This was followed by a sharp decline in the capital markets and the demand for technology, which was reflected in the performance of the portfolios of many venture capital investors. Beyond the current state of the market, however, there are few significant trends emerging that will mark the path for the next few years in the business. The focus of the 20th Growth Capital Symposium is to bring to the forefront views from the leaders on the investment and technology fronts who have managed to break ahead of the curve and are preparing to take advantage of the general market conditions. This is echoed in the sentiment among a growing group of investors who believe that the next few years will be in fact some of the best for venture capital investment. Tuesday, 19th June The Symposium will begin at 10:00am Tuesday morning in Hale Auditorium in the University of Michigan Business School, and will conclude at 5:30pm with a reception at the Museum of Art and a dinner at the Michigan Union.